SOCRATES
02 May 2023
Trial Summary
This study aims to assess the efficacy and clinical outcomes of Stereotactic Body Radiotherapy (SBRT) with the standard of care (SOC) which may include percutaneous ablation (PA), transarterial chemoembolization (TACE), transarterial embolisation (TAE) or transarterial radioembolisation (TARE) in patients with early hepatocellular carcinoma.
Acronym:
SOCRATES
ACTRN/NCT /ethics:
ACTRN12621001444875p
Scientific title:
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)
Sponsor / Cooperative group:
Medical Research Future Fund (MRFF)
Trial & Patient Characteristics
| Cancer Type | Liver |
|---|---|
| Trial Type | Treatment |
| Phase | N/A |
| Age Range | 18 years and older |
| Sex | All |
| Tumour Stream | - |
| Cancer Stage | - |
| Anticipated Start Date | 2022-06-01 |
| Anticipated End Date | 2024-06-30 |
Participating Hospitals
| Hospital | Royal Adelaide Hospital |
|---|---|
| Clinical Trial Coordinator | Anne Milton |
| Anne.Milton@sa.gv.au | |
| Phone | 08 7074 2342 |
| Principal Investigator | Hien Le |
| Recruitment Status | Recruiting |